DaVita Inc (BSP:DVAI34)
R$ 845.04 5.04 (0.6%) Market Cap: 68.90 Bil Enterprise Value: 143.84 Bil PE Ratio: 15.73 PB Ratio: 31.16 GF Score: 79/100

DaVita Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 09:10PM GMT
Release Date Price: R$587.5
Andrew Mok
Barclays Bank PLC, Research Division - Analyst

Good afternoon, and welcome back to the Barclays Global Healthcare Conference. My name is Andrew Mok, and I'll be hosting today's session with DaVita. Joining me today is CFO, Joel Ackerman; and Vice President of Investor Relations, Jim Gustafson. Thank you both for joining. We're glad to have you here.

Joel Ackerman
DaVita Inc. - CFO & Treasurer

Thank you. It's nice to be here.

Jim Gustafson
DaVita Inc. - VP of IR

Thanks a lot.

Questions & Answers

Andrew Mok
Barclays Bank PLC, Research Division - Analyst

Let's start with current trends on mortality and vaccinations. You put out an 8-K yesterday morning. So can you highlight some of the numbers and trends captured in that release?

Joel Ackerman
DaVita Inc. - CFO & Treasurer

Sure. So look, on the quarterly call -- in the quarterly call about a month ago, we highlighted some of the challenges that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot